Westmount Partners »

Fate Therapeutics shares owned by Westmount Partners

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Westmount Partners from 13F filings

Historical chart of Westmount Partners investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Westmount Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Westmount Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 10k 1.25

More positions owned by Westmount Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Caci Intl Cl A (CACI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Wal-Mart Stores (WMT)
International Business Machines (IBM)

View all positions for Westmount Partners

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
Morgan Stanley
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management

View all funds holding Fate Therapeutics